
Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data
Keywords: ABC; ATP-binding cassette; AFP; Alpha fetoprotein; COG; Clinical Oncology Group; CR; Complete response; CSCs; Cancer stem cells; CT; Computerized tomography; DFS; Disease free survival; DP; Disease progression; GPI; Glysyl-phosphatidyl-inosital; HB; Hepat